1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Chronic Cough Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Chronic Cough Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Chronic Cough Market Regional Analysis
6.2 North America Chronic Cough Market Revenue 2017-2027 (US$ Million)
6.3 North America Chronic Cough Market Forecast Analysis
7. North America Chronic Cough Market Analysis – by Drug Class
7.1 Antihistamines
- 7.1.1 Overview
- 7.1.2 Antihistamines: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Corticosteroids
- 7.2.1 Overview
- 7.2.2 Corticosteroids: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Decongestants
- 7.3.1 Overview
- 7.3.2 Decongestants: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Combination Drug
- 7.4.1 Overview
- 7.4.2 Combination Drug: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Antibiotics
- 7.5.1 Overview
- 7.5.2 Antibiotics: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Acid Blockers
- 7.6.1 Overview
- 7.6.2 Acid Blockers: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Other Drug Class
- 7.7.1 Overview
- 7.7.2 Other Drug Class: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Chronic Cough Market Analysis – by Route of Administration
8.1 Oral
- 8.1.1 Overview
- 8.1.2 Oral: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Injections
- 8.2.1 Overview
- 8.2.2 Injections: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Inhalation
- 8.3.1 Overview
- 8.3.2 Inhalation: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Other Route of Administration
- 8.4.1 Overview
- 8.4.2 Other Route of Administration: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Chronic Cough Market Analysis – by Distribution Channel
9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacy: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Online Pharmacy
- 9.2.1 Overview
- 9.2.2 Online Pharmacy: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Chronic Cough Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Chronic Cough Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Chronic Cough Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.1.2 US: North America Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.1.3 US: North America Chronic Cough Market Breakdown, by Distribution Channel
- 10.2.1.2 Canada:
North America Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.2.2 Canada: North America Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.2.3 Canada: North America Chronic Cough Market Breakdown, by Distribution Channel
- 10.2.1.3 Mexico :
North America Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.3.2 Mexico : North America Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.3.3 Mexico : North America Chronic Cough Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Novartis AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Teva Pharmaceutical Industries Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bayer AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mylan N.V.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Amneal Pharmaceuticals, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Cipla Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Reckitt Benckiser Group plc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Aurobindo Pharma Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations